Detection of lung cancer using expired breath analysis by ion mobility spectrometry

Emma Brodrick (Cardiff, United Kingdom), Emma Brodrick, Antony Davies, Paul Neill, Louise Hanna, E. Williams

Source: International Congress 2015 – Developments in lung cancer diagnosis
Session: Developments in lung cancer diagnosis
Session type: Poster Discussion
Number: 2999

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Emma Brodrick (Cardiff, United Kingdom), Emma Brodrick, Antony Davies, Paul Neill, Louise Hanna, E. Williams. Detection of lung cancer using expired breath analysis by ion mobility spectrometry. Eur Respir J 2015; 46: Suppl. 59, 2999

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Proteomics and screening of lung cancer: Biomarkers selection by mass spectrometry and ELISA in the exhaled breath condensate (EBC)
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013


Differences in volatile organic compounds (VOC) determined in exhaled breath in two populations of lung cancer (LC): With and without COPD
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013


Early detection of lung cancer in exhaled breath condensate using miRNA markers
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015


Breath collection related factors may influence electronic nose ability to detect lung cancer
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015


Using exhaled breath profiles in the discrimination between COPD, lung cancer and their co-morbidity
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015

Analysis of exhaled breath with electronic nose and diagnosis of lung cancer by support vector machine
Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer
Year: 2013


Analysis of exhaled breath with electronic nose and discrimination of lung cancer and COPD by logistic regression analysis
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013


Volatile organic compounds of exhaled breath in lung cancer and lung inflammatory diseases
Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer
Year: 2013


Volatile organic compounds in exhaled breath samples as potential biomarkers in early diagnosis of lung cancer – (Ege translational pulmonology research group [EgeTPAG])
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016

LATE-BREAKING ABSTRACT: New algorithm of lung cancer diagnosis by analysis of exhaled breath with electronic nose and multifactorial logistic regression method
Source: International Congress 2014 – Thoracic tumours: news from the lab
Year: 2014


Analysis of exhaled breath with electronic nose and diagnosis of lung cancer by multifactorial logistic regression analysis
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013


Automated target-FISH lung cancer detection (LCD) test of induced sputum
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015


Breath analysis by ion mobility spectrometry in COPD and lung cancer patients
Source: Annual Congress 2009 - Quality control in lung function and new developments
Year: 2009


The research on early detection of lung cancer with exhaled volatile organic compounds
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014

Detection of early stage lung cancer by electronic nose
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013


Exhaled breath temperature in NSCLC: Could be a new non invasive marker?
Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours
Year: 2014



Evaluation of spirometry test as monitoring tool in lung cancer patients
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016

Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014

Metabolomic analysis of serum samples from patients with lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014


Breath analysis by ion mobility spectrometry allows to discriminate COPD from lung cancer patients.
Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Year: 2018